Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Recent & Breaking News (TSXV:CZO)

Ceapro Inc. to Present at the Virtual Investor Fireside Chat Series

GlobeNewswire June 9, 2020

Ceapro Inc. Reports 2020 First Quarter Financial Results and Highlights

GlobeNewswire May 28, 2020

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

GlobeNewswire May 26, 2020

Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights

GlobeNewswire April 16, 2020

Ceapro Inc. to Present at the April 2020 Virtual Investor Summit

GlobeNewswire April 15, 2020

Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch

GlobeNewswire February 14, 2020

Ceapro Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference

GlobeNewswire February 10, 2020

Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

GlobeNewswire February 5, 2020

Ceapro Inc. Secures DTC Eligibility for Publicly Traded Shares Under Ticker OTCQZ: CRPOF

GlobeNewswire January 31, 2020

Ceapro Announces Grant of Stock Options and Restricted Share Units

GlobeNewswire January 6, 2020

Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids

GlobeNewswire December 17, 2019

Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights

GlobeNewswire November 13, 2019

Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides

GlobeNewswire October 29, 2019

Ceapro Begins Trading on the OTCQX Best Market

GlobeNewswire October 16, 2019

Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research

GlobeNewswire September 25, 2019

Ceapro Inc. to Present at the Fall Investor Summit in New York

GlobeNewswire September 10, 2019

Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights

GlobeNewswire August 28, 2019

Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University

GlobeNewswire August 27, 2019

Ceapro Inc. Announces Signing of a Contribution Agreement with National Research Council of Canada

GlobeNewswire August 15, 2019

Ceapro Announces Results of 2019 Shareholders' Meeting

GlobeNewswire June 10, 2019